跳至主要内容
临床试验/NCT02048891
NCT02048891已完成4 期

Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
3
试验地点
1
主要终点
Fetal Heart Activity 1 Month After Oocyte Retrieval

研究概览

简要总结

Ovulation trigger is needed in in vitro fertilization (IVF) to get mature eggs. Routinely, human chorionic gonadotropin (hCG) is used for that purpose given its similarity to the natural hormone that does this job in a natural cycle (luteinizing hormone, LH). In a natural cycle another hormone takes part in the process (follicle stimulating hormone, FSH). To induce a natural-like ovulation surge that includes LH and FSH , gonadotropin releasing hormone (GnRH) agonist can be given.

The purpose of this study is to find out which approach may work better in IVF patients who experienced 4 IVF failures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • IVF patients with at least 4 consecutive failures.
  • On trigger day, no more than 10 follicles of 12 mm and up

排除标准

  • History of moderate or severe OHSS.

研究组 & 干预措施

hCG trigger

Active Comparator

Ovulation trigger with Ovitrelle 250 microgram, luteal support with vaginal progesterone: gel Crinone 8% daily.

干预措施: hCG trigger (Drug)

GnRH agonist trigger

Experimental

ovulation trigger with Decapeptyl 0.2 mg, luteal support with 2 injections of 1,500 U hCG.

干预措施: GnRH agonist trigger (Drug)

结局指标

主要结局

Fetal Heart Activity 1 Month After Oocyte Retrieval

时间窗: 1 month after oocyte retrieval

Fetal heart activity as seen by vaginal ultrsound imaging 1 month after oocyte retrieval

次要结局

  • Patients Comfort During the Luteal Phase(During 2 weeks from day of oocyte retrieval)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shahar Kol MD

Director, IVF Unit

Rambam Health Care Campus

研究点 (1)

Loading locations...

相似试验